Yes, closing of the Third Eye loan and TSX issues take away a large degree of uncertainty.

Now, when will we get the BETonMACE 188 adjudicated event SSRA news? Should be very soon. Would be great if before BIO International early June (FYI RVX presentation June 6, Zenith presentation June 4).

Will there be any BETonMACE trial changes as a results of the SSRA? If no, this really solidifies the trial end timeline and these narrowed bookends may bring in investors currently on sidelines.

When will the Renal and Fabry trials start? Start dates might be contigent upon SSRA and potential trial changes. The decision on trial changes may impact funding availability/allocation for these pending trials.

What's the deal with the Bloom Burton Proposed Offering of Units? Was this just a fallback plan in case the Third Eye loan didn't close? Is this offering in place to fund the Renal and Fabry trials? Is this offering in place to provide additional funds for BETonMACE adaptations post-SSRA if necessary?